Alirocumab in Patients With Acute Myocardial Infarction: A Randomized Controlled Double-Blinded Study
Phase of Trial: Phase IV
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Alirocumab (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 07 Feb 2017 Status changed from not yet recruiting to recruiting.
- 09 Nov 2016 Planned initiation date changed from 1 Oct 2016 to 1 Nov 2016.